CA
DMAAR

Crossingbridge Advisors’s Drugs Made In America Acquisition Corp. Rights DMAAR Stock Holding History

Crossingbridge Advisors’s Portfolio DMAAR Stock Details DMAAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$106K Hold
850,000
– – 0.09% 64
2025
Q1 		$807K Buy
+850,000
New +$807K 0.42% 44